Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal magnesium sulfate added to Marcaine for prevention of shivering during cesarean section
IRCT201101055182N4Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of magnesium sulfate and bupivacaine in postanesthetic shivering (PAS) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Control of shivering during cesarean section surgery. Started Jan 2011; status: completed.
02
Drugs
magnesium sulfatebupivacaine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT201101055182N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201101055182N4.